Criticisms Mount On Drug IP Proposals In Pacific Trade Pact

Law360, New York (December 11, 2013, 4:39 PM EST) -- Potential provisions in the Trans-Pacific Partnership on drug patent protections and the length of copyright terms came under fire recently, with Democratic lawmakers, library associations and consumer groups voicing concern over proposals that are currently on the table.

In letters sent Friday and Monday, several House Democrats urged the Obama administration to reconsider its reported proposals for handling pharmaceutical patents in the TPP, a trade agreement under negotiation between the U.S. and 11 other Pacific Rim countries. Separately on Friday, a slew of library, digital rights...
To view the full article, register now.